Williams Jones Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,045
Closed -$370K 564
2023
Q2
$370K Sell
3,045
-1,150
-27% -$153K 0.01% 391
2023
Q1
$644K Sell
4,195
-950
-18% -$157K 0.01% 327
2022
Q4
$924K Buy
+5,145
New +$841K 0.02% 277

Other funds holding MRNA

Williams Jones Wealth Management's MRNA Position: Q3 2023 in Review

Williams Jones Wealth Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 3,045 shares — an estimated $370K sold.

Williams Jones Wealth Management first reported a position in MRNA in Q4 2022 and held it in 3 quarters. The position peaked at $924K in Q4 2022. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Williams Jones Wealth Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Williams Jones Wealth Management sold 3,045 Moderna shares in Q3 2023, an estimated $370K.
  • Williams Jones Wealth Management first reported a position in Moderna in Q4 2022 and held it in 3 quarters.
  • Williams Jones Wealth Management's Moderna position peaked at $924K in Q4 2022.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Williams Jones Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.